Emilia Hollingshed, 1, courageously fights a rare form of germ cell cancer, inspiring her family with every step of her ...

Natera’s fair value estimate has been raised to $202.50 from $193.80, reflecting renewed confidence in the company’s growth trajectory. The price target increase highlights optimism about Natera’s ...

Cancer has become a serious problem in today's life, involving more than 200 types. Know how small changes and symptoms can ...

Edited by Joan Strassmann, Washington University in St. Louis, St. Louis, MO; received December 26, 2024; accepted April 11, 2025 ...

As a result of a domestic research team reclassifying the diagnosis of pediatric malignant brain tumors according to the ...

Holding both clinics and their respective doctors jointly liable, the consumer panel directed them to pay a total ...

A major risk factor for testicular cancer is an undescended testicle. In normal development, the testes fall or descend from ...

Natera Inc. (NASDAQ: NTRA) is one of the best growth stocks to buy now. On September 30, Natera announced the publication of ...

A pro-Trump counterprotestor on a bicycle said to be at a No Kings rally in San Diego on Saturday rode a lonely road—save for ...

Adoptive T cell therapy has transformed cancer treatment, with chimeric antigen receptor (CAR) T cell therapy demonstrating remarkable clinical success in hematological malignancies. By genetically ...